BOMBAY BURMAH | R J BIO-TECH | BOMBAY BURMAH/ R J BIO-TECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -166.1 | - | - | View Chart |
P/BV | x | 2.7 | - | - | View Chart |
Dividend Yield | % | 0.1 | 0.0 | - |
BOMBAY BURMAH R J BIO-TECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BOMBAY BURMAH Mar-23 |
R J BIO-TECH Mar-22 |
BOMBAY BURMAH/ R J BIO-TECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,116 | 12 | 9,336.0% | |
Low | Rs | 781 | 5 | 15,247.1% | |
Sales per share (Unadj.) | Rs | 2,382.5 | 14.7 | 16,235.6% | |
Earnings per share (Unadj.) | Rs | -110.6 | -4.3 | 2,586.4% | |
Cash flow per share (Unadj.) | Rs | -76.3 | -4.2 | 1,814.3% | |
Dividends per share (Unadj.) | Rs | 1.20 | 0 | - | |
Avg Dividend yield | % | 0.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 578.1 | -53.2 | -1,087.5% | |
Shares outstanding (eoy) | m | 69.77 | 9.47 | 736.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 0.6 | 68.4% | |
Avg P/E ratio | x | -8.6 | -2.0 | 429.6% | |
P/CF ratio (eoy) | x | -12.4 | -2.0 | 612.4% | |
Price / Book Value ratio | x | 1.6 | -0.2 | -1,021.8% | |
Dividend payout | % | -1.1 | 0 | - | |
Avg Mkt Cap | Rs m | 66,154 | 81 | 81,869.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 7,693 | 6 | 130,609.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 166,229 | 139 | 119,615.1% | |
Other income | Rs m | 4,559 | 7 | 67,648.2% | |
Total revenues | Rs m | 170,789 | 146 | 117,211.3% | |
Gross profit | Rs m | 2,513 | 12 | 21,548.7% | |
Depreciation | Rs m | 2,393 | 1 | 357,128.4% | |
Interest | Rs m | 4,253 | 58 | 7,304.3% | |
Profit before tax | Rs m | 427 | -40 | -1,054.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 8,142 | 0 | - | |
Profit after tax | Rs m | -7,715 | -40 | 19,055.0% | |
Gross profit margin | % | 1.5 | 8.4 | 18.0% | |
Effective tax rate | % | 1,907.9 | 0 | - | |
Net profit margin | % | -4.6 | -29.1 | 15.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 84,148 | 3 | 2,901,649.0% | |
Current liabilities | Rs m | 54,411 | 484 | 11,252.9% | |
Net working cap to sales | % | 17.9 | -345.9 | -5.2% | |
Current ratio | x | 1.5 | 0 | 25,785.8% | |
Inventory Days | Days | 117 | 3 | 4,516.3% | |
Debtors Days | Days | 86 | 7,265,677 | 0.0% | |
Net fixed assets | Rs m | 72,183 | 16 | 443,384.9% | |
Share capital | Rs m | 140 | 95 | 147.5% | |
"Free" reserves | Rs m | 40,195 | -598 | -6,720.7% | |
Net worth | Rs m | 40,335 | -503 | -8,012.5% | |
Long term debt | Rs m | 42,709 | 33 | 128,756.7% | |
Total assets | Rs m | 156,779 | 19 | 816,985.0% | |
Interest coverage | x | 1.1 | 0.3 | 361.3% | |
Debt to equity ratio | x | 1.1 | -0.1 | -1,606.9% | |
Sales to assets ratio | x | 1.1 | 7.2 | 14.6% | |
Return on assets | % | -2.2 | 92.4 | -2.4% | |
Return on equity | % | -19.1 | 8.0 | -237.8% | |
Return on capital | % | 5.6 | -3.8 | -149.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0.1 | 2.5 | 5.0% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 210 | 4 | 5,992.3% | |
Fx inflow | Rs m | 604 | 0 | - | |
Fx outflow | Rs m | 210 | 4 | 5,992.3% | |
Net fx | Rs m | 394 | -4 | -11,256.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 24,737 | -47 | -52,441.3% | |
From Investments | Rs m | -13,339 | NA | - | |
From Financial Activity | Rs m | -11,614 | 47 | -24,832.7% | |
Net Cashflow | Rs m | -116 | 0 | 29,735.9% |
Indian Promoters | % | 55.9 | 60.3 | 92.7% | |
Foreign collaborators | % | 18.1 | 0.0 | - | |
Indian inst/Mut Fund | % | 8.7 | 0.0 | - | |
FIIs | % | 7.5 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 26.0 | 39.7 | 65.4% | |
Shareholders | 39,872 | 245 | 16,274.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare BOMBAY BURMAH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | BOM.BURMAH | R J BIO-TECH |
---|---|---|
1-Day | 1.15% | 4.92% |
1-Month | -6.25% | 0.89% |
1-Year | 100.04% | -30.41% |
3-Year CAGR | 11.86% | -20.28% |
5-Year CAGR | 4.07% | -26.08% |
* Compound Annual Growth Rate
Here are more details on the BOM.BURMAH share price and the R J BIO-TECH share price.
Moving on to shareholding structures...
The promoters of BOM.BURMAH hold a 74.1% stake in the company. In case of R J BIO-TECH the stake stands at 60.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BOM.BURMAH and the shareholding pattern of R J BIO-TECH.
Finally, a word on dividends...
In the most recent financial year, BOM.BURMAH paid a dividend of Rs 1.2 per share. This amounted to a Dividend Payout ratio of -1.1%.
R J BIO-TECH paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of BOM.BURMAH, and the dividend history of R J BIO-TECH.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.